The same enzyme is responsible for the activation of transforming growth factor-␤-like signalling molecules and the processing of fibrillar procollagens. This finding implicates a metalloendoprotease in the control of cell behavior and matrix assembly during morphogenesis.
Procollagens I, II and III are the precursors of the major fibrillar collagens in vertebrate matrices [2] . They are homotrimeric or heterotrimeric molecules that contain a central triple-helical, fibril-forming domain flanked by amino and carboxyl propeptide domains (Fig. 1) . Fibrils cannot form unless the propeptides are removed; their cleavage by specific endoproteases is therefore a necessary step in fibrillogenesis. In tissues such as cartilage and bone, this processing of procollagens is of major importance for normal morphogenesis because of the large amount of matrix and the critical role of the collagen fibril scaffold in the structure and function of the matrix.
The procollagen C-proteinase (PCP), responsible for removing the C-propeptide, is an N-glycosylated metalloprotease that requires calcium for optimal activity [3] . The activity of PCP is stimulated by another glycoprotein, the procollagen C-proteinase enhancer (PCPE) [4] . PCP and PCPE bind to the C-propeptide and to each other. Both chick and mouse PCPs have been purified and shown to cleave the two chains of procollagen I at a specific Ala-Asp bond. Interestingly, many of the properties of PCP, such as its molecular mass and calcium requirement, are close to those expected for the mature form of BMP-1, a metalloprotease with bone-inductive activity that was first isolated from osteogenetic fractions of bone together with other bone morphogenetic proteins (BMPs) [5] .
It had been known for a long time that extracts of demineralized bone could induce new bone formation, but the molecular characteristics of the active components did not become clear until the bone morphogenetic proteins were cloned. The BMPs are members of the transforming growth factor-␤ (TGF-␤) superfamily, with the exception of BMP-1, which is homologous to proteins such as the product of the zygotic dorsal-ventral patterning gene tolloid (tld) in Drosophila, the crayfish digestive endopeptidase astacin, and the sea urchin proteins SpAN and BP10 [6] . Each of these proteins contains several domains: an amino-terminal region of astacin-like protease structure, and varying numbers of EGF-like repeats and domains involved in protein-protein interactions (CUB domains) [7] . In Drosophila, the tolloid protease is involved in processing the precursor of the BMP-2/4-like product of the decapentaplegic (dpp) gene; BMP-1 may likewise activate latent forms of BMPs or other TGF-␤-like molecules.
The similarities between BMP-1 and PCP led Kessler et al. [1] to compare recombinant BMP-1 (rBMP-1) with purified mouse PCP in several ways. First, they checked whether rBMP-1 has PCP activity. Many proteolytic enzymes can mimic the activity of PCP by removing the C-propeptide from procollagen I, but only PCP cleaves at a specific Ala-Asp bond. With procollagen I as substrate, Kessler et al. [1] showed not only that rBMP cleaved the molecule into fragments of the correct size, as estimated by polyacrylamide gel electrophoresis, but also that the carboxyl fragment had the correct Asp residue at its amino terminus. In addition, procollagen III present as a contaminant in the procollagen I preparation was cleaved at the correct Gly-Asp bond. Furthermore, the activity of rBMP-1 with procollagen I as substrate was stimulated by the enhancer protein PCPE, and several inhibitors had similar effects on PCP and on BMP-1.
In further experiments, Kessler et al. [1] showed that rBMP-1 and PCP bound to and could be eluted from lysyl-Sepharose and C-propeptide-Sepharose columns under the same conditions. Antibodies directed against rBMP-1 recognized PCP in immunoblots, and although rBMP-1 and mouse PCP migrated as two bands on gels, after treatment with peptide-N-glycosidase F the two proteins migrated as a single band. Finally, partial sequencing of two fragments of mouse PCP showed sequences consistent with those of human and mouse BMP-1. Thus, PCP and BMP-1 seem to be identical proteins.
As TGF-␤-like or BMP-1/tolloid-like proteins are implicated in various patterning processes in diverse organisms from flies to mammals [6] , the fact that BMP-1 is identical to one of the two proteases that cleave procollagen molecules raises the exciting possibility that it represents a nexus for integrating cellular responses to cytokines and the assembly of extracellular matrices. In its simplest form, the idea would be that BMP-1, through its ability to activate TGF-␤/BMP-like molecules within complexes of latent precursors and TGF-␤ binding proteins, indirectly regulates matrix production, while at the same time it controls collagen fibril assembly by removing the C-propeptide from procollagens (Fig. 1) . This is almost certainly too simplistic, however, as several observations indicate the existence of more than one BMP-1-like protease.
In Drosophila, for example, a close homologue of the tolloid gene, tolloid-related-1 (tlr-1), shows distinct expression patterns in late-stage embryos, suggesting the existence of a homologue of BMP-1 with a tissue-specific function [8] . Also, two PCPs with slightly different properties have been purified from chick embryo calvaria and tendons [3, 9] . And as the BMP-1 gene generates alternatively spliced transcripts encoding PCP and a longer protein, mammalian tolloid (mtld) [1] , it is possible that a whole family of BMP-1-like proteases exist in mammals. Members of such a family could have overlapping but different activities and specificities for various TGF-␤ superfamily members and/or different types of procollagens and other non-collagenous matrix molecules. The cleavage site for PCP in fibrillar procollagens lies within a non-triple-helical domain, and the enzyme does not distinguish between single procollagen chains or folded trimeric molecules. Thus, PCP or related proteases may cleave sites in non-collagenous matrix molecules as well as those in fibrillar procollagens.
But should the activities of these enzymes be restricted to collagenous proteins, there are plenty of potential substrates. At the latest count there were about 35 genes in the collagen superfamily, encoding polypeptide subunits of about 20 different types of homotrimeric or heterotrimeric molecule [2] . Not all of these types are proteolytically cleaved like procollagens I, II and III to yield fibril-forming Procollagen C-proteinase (PCP = BMP-1) serves as a processing enzyme for procollagen and for molecules belonging to the TGF-␤ superfamily. In conjunction with a glycoprotein enhancer (PCPE), it cleaves procollagen between the triple-helical domain (pink) and the C-propeptide (blue) to produce a pN-collagen product (which will be further cleaved by an N-proteinase; not illustrated). As PCP binds to the C-propeptide and PCPE, the PCPE/C-propeptide complex may serve to sequester PCP within the matrix. As a processing enzyme for cytokines in the TGF-␤ superfamily, PCP may cleave precursors while they are complexed with binding proteins such as the latent TGF-␤ binding proteins (LTBP). triple-helical units, but some degree of processing has been demonstrated for many and is likely for others. Particularly significant may be the processing of so-called minor fibrillar procollagens, various combinations of polypeptide products of collagen V and XI genes [2] . These molecules are expressed in tissue-specific patterns, copolymerize with the major collagens I and II in fibrils, and regulate the properties of the fibrils and fibrillar scaffolds. For example, mutations in two of the genes in this group, Col11a1 and Col5a2, result in increased collagen fibril diameters, dramatic reduction in tensile strength and cohesive properties of extracellular matrices, and alterations in cell differentiation and/or proliferation [10, 11] . Whereas procollagens I, II and III are cleaved by both procollagen N-proteinases and Cproteinases, the minor procollagens V/XI seem to be processed only at the C-propeptide. Their cleavage by PCP is therefore a potential mechanism for controlling their incorporation into fibrils and regulating the mechanical properties of fibrillar scaffolds.
The report by Kessler et al. [1] ties together ideas and data from fields as diverse as those of patterning processes in flies, sea urchins and frogs, bone induction in mammals, and collagen fibril assembly. This is the sort of unexpected discovery that deserves a response such as Hecate's in Macbeth: "O, well done! I commend your pains; And every one shall share i' th' gains." The stage is set for further developments in this interesting story.
